Skip to main content

Peer Review reports

From: Antioxidative stress protein SRXN1 can be used as a radiotherapy prognostic marker for prostate cancer

Original Submission
6 Aug 2022 Submitted Original manuscript
2 Oct 2022 Reviewed Reviewer Report
7 Oct 2022 Reviewed Reviewer Report - Naresh Kumar Saidha
8 Feb 2023 Reviewed Reviewer Report - Research Square Reviewer 1
9 Mar 2023 Author responded Author comments - Haiyong Zhou
13 Mar 2023 Author responded Author comments - Haiyong Zhou
Resubmission - Version 2
9 Mar 2023 Submitted Manuscript version 2
21 Jul 2023 Reviewed Reviewer Report
8 Aug 2023 Author responded Author comments - Haiyong Zhou
Resubmission - Version 3
8 Aug 2023 Submitted Manuscript version 3
Publishing
4 Sep 2023 Editorially accepted
19 Sep 2023 Article published 10.1186/s12894-023-01319-1

You can find further information about peer review here.

Back to article page